does retatrutide cause cancer & Pancreatic Research Phase III retatrutide study demonstrates

That is the biological rationale behind the question, though the article is careful to separate rationale from proof

If they dont, then you should speak with your doctor

Journal of General Internal Medicine

Adverse Effects and Long-Term Safety Concerns While GLP-1 receptor agonists have shown significant benefits, their widespread use is limited by potential side effects such as gastrointestinal distress, pancreatitis risk, and concerns over long-term metabolic effects

Originally developed to manage type 2 diabetes, these medications mimic the GLP-1 hormone, which plays a key role in regulating appetite, slowing gastric emptying, and enhancing feelings of fullness